EU governments reportedly brace for further delays to vaccine rollout
This, according to a Bloomberg report citing a diplomatic note on further delays in distribution of AstraZeneca's vaccine as the manufacturer remains "problematic".
Adding to that is Johnson & Johnson, whose vaccine should be approved by the EMA this week, has yet to provide a delivery schedule for its vaccine.
With several countries even temporarily suspending what little of the AstraZeneca vaccine supply they have, there are growing problems for the EU and its vaccination initiative.
